作者: Waiel Al-Kahiry , Homam Sharshira , Amal Ghanem , Maha El-gammal , Irene Lewis Mikhael
DOI: 10.1007/S12288-016-0745-0
关键词:
摘要: sCD14 is an acute phase reactant; few studies reported its prognostic value in B-CLL patients. This gave us the impetus to conduct this study. study enrolled 40 newly diagnosed Egyptian patients, presented Hematology Department of Medical Research Institute Alexandria University. The ZAP-70 was determined by flow cytometry whereas serum concentration human sandwich ELISA method. mean level significantly higher among patients with positive ZAP-70, Binet stage C, Rai III–IV and high risk CLL index. It showed a significant correlation percentage expression negative hemoglobin concentration. Serum could be used assess initially as additional marker, especially low resources areas where not available.